Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,016 | 105 | 99.9% |
| Education | $5.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,377 | 17 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $450.89 | 11 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $419.12 | 15 | $0 (2018) |
| Lilly USA, LLC | $365.65 | 16 | $0 (2022) |
| Amgen Inc. | $278.33 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $152.52 | 3 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $123.15 | 7 | $0 (2023) |
| Boston Scientific Corporation | $104.35 | 1 | $0 (2019) |
| Exact Sciences Corporation | $102.21 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $99.35 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $218.16 | 8 | Amgen Inc. ($142.39) |
| 2023 | $74.74 | 3 | Exact Sciences Corporation ($26.44) |
| 2022 | $84.59 | 5 | Lilly USA, LLC ($36.76) |
| 2021 | $241.84 | 10 | Medtronic, Inc. ($69.24) |
| 2020 | $56.43 | 4 | Amgen Inc. ($16.60) |
| 2019 | $878.99 | 20 | Lilly USA, LLC ($284.85) |
| 2018 | $1,376 | 27 | Janssen Pharmaceuticals, Inc ($853.70) |
| 2017 | $1,090 | 29 | Janssen Pharmaceuticals, Inc ($399.09) |
All Payment Transactions
106 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Inflammation | ||||||
| 09/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: Oncology | ||||||
| 06/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Inflammation | ||||||
| 03/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Oncology | ||||||
| 02/28/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $91.57 | General |
| Category: Inflammation | ||||||
| 01/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Inflammation | ||||||
| 01/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Oncology | ||||||
| 10/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Oncology | ||||||
| 08/22/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Gastroenterology | ||||||
| 10/19/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Diabetes | ||||||
| 10/06/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Diabetes | ||||||
| 05/05/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Gastroenterology | ||||||
| 03/30/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: RESPIRATORY | ||||||
| 03/15/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Gastroenterology | ||||||
| 11/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Gastroenterology | ||||||
| 10/06/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $13.30 | General |
| Category: Cardiovascular | ||||||
| 09/29/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2021 | Medtronic, Inc. | ClosureFast (Device) | Food and Beverage | In-kind items and services | $69.24 | General |
| Category: EndoVenous Therapies | ||||||
| 06/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Gastroenterology | ||||||
| 02/24/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 483 | 967 | $144,210 | $77,005 |
| 2022 | 7 | 484 | 986 | $143,770 | $78,849 |
| 2021 | 8 | 559 | 1,153 | $177,635 | $100,559 |
| 2020 | 11 | 613 | 1,266 | $185,075 | $89,553 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 572 | $102,550 | $50,989 | 49.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 111 | 111 | $19,425 | $14,610 | 75.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 74 | $9,250 | $4,379 | 47.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $4,675 | $2,475 | 52.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 123 | 123 | $3,075 | $2,294 | 74.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $3,375 | $1,439 | 42.6% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Office | 2023 | 13 | 26 | $1,180 | $617.59 | 52.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $440.00 | $119.40 | 27.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 24 | $240.00 | $81.84 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 159 | 596 | $104,300 | $52,818 | 50.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 120 | 120 | $21,000 | $16,145 | 76.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 84 | $10,500 | $5,294 | 50.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 123 | 123 | $3,090 | $2,314 | 74.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $3,825 | $1,756 | 45.9% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Office | 2022 | 16 | 17 | $765.00 | $421.41 | 55.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 29 | $290.00 | $99.67 | 34.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 177 | 703 | $123,025 | $66,403 | 54.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 129 | 129 | $22,575 | $17,810 | 78.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 112 | $14,000 | $7,586 | 54.2% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 14 | 16 | $6,800 | $2,672 | 39.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 127 | 127 | $3,175 | $2,439 | 76.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $5,175 | $2,215 | 42.8% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 14 | 19 | $1,805 | $787.36 | 43.6% |
| 98925 | Osteopathic manipulative treatment to 1-2 body regions | Office | 2021 | 12 | 24 | $1,080 | $647.04 | 59.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 192 | 702 | $122,850 | $54,470 | 44.3% |
About Dr. Walter Flesner, D.O
Dr. Walter Flesner, D.O is a Family Medicine healthcare provider based in Cape Coral, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922063742.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Walter Flesner, D.O has received a total of $4,021 in payments from pharmaceutical and medical device companies, with $218.16 received in 2024. These payments were reported across 106 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,016).
As a Medicare-enrolled provider, Flesner has provided services to 2,139 Medicare beneficiaries, totaling 4,372 services with total Medicare billing of $345,966. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cape Coral, FL
- Active Since 04/18/2006
- Last Updated 09/14/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1922063742
Products in Payments
- XARELTO (Drug) $855.41
- INVOKANA (Drug) $521.79
- FARXIGA (Drug) $450.89
- JARDIANCE (Drug) $250.71
- JANUMET (Drug) $206.32
- EMGALITY (Drug) $187.05
- XIFAXAN (Drug) $154.97
- Otezla (Drug) $142.39
- Aimovig (Biological) $135.94
- GENERAL VASCULAR INTERVENTION (Device) $104.35
- Cologuard Collection Kit (Device) $102.21
- SOLIQUA (Drug) $99.35
- REMODULIN (Drug) $98.43
- BELSOMRA (Drug) $87.20
- UBRELVY (Drug) $79.90
- ClosureFast (Device) $69.24
- JANUVIA (Drug) $65.60
- TRELEGY ELLIPTA (Drug) $57.26
- ASMANEX (Drug) $50.72
- SUBLOCADE (Drug) $49.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cape Coral
Dr. David Phillips, Do, DO
Family Medicine — Payments: $12,857
Dr. Emie Kuyumjian, M.d, M.D
Family Medicine — Payments: $12,798
Dr. Joanna Muller Carioba, M.d, M.D
Family Medicine — Payments: $9,638
Dr. William Hayes, D.o, D.O
Family Medicine — Payments: $9,480
Lucia Huffman, M.d, M.D
Family Medicine — Payments: $8,761
Dr. Trevor Cox, D.o, D.O
Family Medicine — Payments: $7,866